According to filings with the U.S. Securities and Exchange Commission, Vida Diagnostics is raising $13,543,509.00 in new funding. Sources indicate that as part of senior management President and Chief Executive Officer, Susan Wood played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Vida Diagnostics
VIDA modernizes lung and respiratory care by empowering healthcare organizations and physicians. We enable confident, decision clarity through both quantitative data intelligence and impactful visualizations. Our AI-enabled software solutions seamlessly integrate within current workflow to provide both structural and functional insights at the point of care to detect, diagnosis, treat and track lung disease. Our continued collaboration with industry thought leaders and healthcare organizations advance clinical care and validate novel therapeutics as we execute clinical trials through clinical trial services. The result? We help you improve patient outcomes, streamline care coordination and drive efficiencies. VIDA is unique in its comprehensive approach to lung and respiratory care, as our solutions are built upon a foundation of proven quality and decades of expertise. From clinical and research leadership in derived insights, to partnerships with physicians and institutions, VIDA modernizes lung and respiratory care.

To learn more about Vida Diagnostics, visit http://vidalung.ai/

Contact:
Susan Wood, President and Chief Executive Officer
855-900-8432
https://www.linkedin.com/in/susan-wood-b175242/

SOURCE: http://www.intelligence360.io
Copyright (c) 2023 SI360 Inc. All rights reserved.